Cholangiocarcinoma is rare and extremely aggressive. It is also known as bile duct cancer and it may cause high levels of carcinoembryonic antigen (CEA) and CA19-9 in the blood. Fewer than 10% of patients survive five years after diagnosis. Survival is even lower for patients diagnosed at a metastatic stage.
top of page
bottom of page